Literature DB >> 24225746

An intervention to improve the timing of vancomycin levels.

Stacy E F Melanson1, Aleksandar S Mijailovic, Aileen P M Wright, Paul M Szumita, David W Bates, Milenko J Tanasijevic.   

Abstract

OBJECTIVES: Blood samples for vancomycin levels are often drawn too early, leading to potential misinterpretation of results. However, only a few studies describe interventions to reduce mistimed vancomycin levels.
METHODS: We implemented an information technology (IT)-based intervention that provided educational instructions to nurses and determined the percentage of levels drawn too early for 27 months before (n = 6,291) and 14 months after (n = 3,608) the intervention. In addition, we conducted nurse interviews (n = 40) and dataset analysis to assess the root causes of mistimed levels.
RESULTS: The percentage of vancomycin timing errors decreased from 39% (2,438/6,291) to 32% (1,137/3,608), though in a time series analysis this decrease was not statistically significant (P = .64). Four common causes of mistimed levels were found: (1) unclear provider orders, (2) scheduling levels to be drawn with morning laboratory tests, (3) lack of communication between providers, and (4) failure to adjust the blood draw in relation to the previous dose.
CONCLUSIONS: A real-time, IT-based intervention that links the timing of levels with medication administration might have a more substantial impact.

Entities:  

Keywords:  IT intervention; Patient safety; Quality; Therapeutic drug monitoring; Vancomycin

Mesh:

Substances:

Year:  2013        PMID: 24225746     DOI: 10.1309/AJCPKQ6EAH7OYQLB

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  To err is human: lessons from patient safety research for transplant care.

Authors:  Lipika Samal; David W Bates
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

2.  Barriers and facilitators of appropriate vancomycin use: prescribing context is key.

Authors:  Joanne Oi Sze Chan; Melissa Therese Baysari; Jane Ellen Carland; Indy Sandaradura; Maria Moran; Richard Osborne Day
Journal:  Eur J Clin Pharmacol       Date:  2018-07-28       Impact factor: 2.953

3.  Gap Analysis for the Conversion to Area Under the Curve Vancomycin Monitoring in a Small Rural Hospital.

Authors:  Jennifer L Cole
Journal:  Fed Pract       Date:  2020-06

4.  Evaluating the Effect of a Web-Based E-Learning Tool for Health Professional Education on Clinical Vancomycin Use: Comparative Study.

Authors:  Stuart Evan Bond; Shelley P Crowther; Suman Adhikari; Adriana J Chubaty; Ping Yu; Jay P Borchard; Craig Steven Boutlis; Wilfred Winston Yeo; Spiros Miyakis
Journal:  JMIR Med Educ       Date:  2018-02-26

5.  Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes.

Authors:  Oscar Santalo; Umima Baig; Mara Poulakos; Daniel Brown
Journal:  Pharmacy (Basel)       Date:  2016-11-10

6.  Experience of Vancomycin Therapeutic Drug Monitoring in Two Multidisciplinary Hospitals in Latvia.

Authors:  Inga Mauliņa; Karīna Darbiniece; Lāsma Miķelsone-Jansone; Renārs Erts; Dace Bandere; Angelika Krūmiņa
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.